World Leading Biopharma Pricing, Access and Evidence Congress event is making its way online

 


Thank you for making 2020 a success! See you in 2021


Coming to you live, from wherever you are

Already registered?

Login & Access Content Now
 

Not yet registered?

Enquire for 2021

 

 
 

Live feed

 

 

Event platform now live!  
 

Access it for networking and pre- congress content You should've received your login details by now, if not email Hayley.Atkinson@terrapinn.com

 

LOG IN NOW & START NETWORKING

 

 

Join us

Pharma Pricing Market Access & Evidence Virtual Congress goes live in...

Pharma Pricing Market Access & Evidence Virtual Congress Countdown

 

BOOK NOW

Streaming in channel:
Keynotes

Bharat Tewarie

Streaming in channel:
HTA

Streaming in channel:
Value

Streaming in channel:
Affordability

 

 

Streaming in channel:
Evidence

Streaming in channel:
Rare Diseases

Streaming in channel:
Emerging Markets

 

 

Streaming in channel:
Governmental Affairs

Streaming in channel:
Patient Advocacy

Streaming in channel:
Pricing & Market Access

 

 

Streaming in channel:
Payer Engagement & Policy

Streaming in channel:
The Far East & Australasia

Streaming in channel:
Big Data, Digital & Analytics

 

 

Streaming in channel:
Managed Access Entry Agreements

Streaming in channel:
Contracting & Price Tendering

Streaming in channel:
Biosimilars & Value Added Medicines

 

 

Streaming in channel:
Advanced Therapies & Patient Centricity

 

 

 

Title Sponsor

Platinum Sponsor

Platinum Sponsor

Platinum Sponsor

Silver Sponsor

Silver Sponsor

Silver Sponsor

Silver Sponsor

Silver Sponsor

Silver Sponsor

Silver Sponsor

Silver Sponsor

 

 

Thousands

of attendees

200+

speakers

10

channels

3

day

 
 


PPMA & Evidence Congress is going virtual for 2020!

The Pricing, Market Access and Evidence Congress arrives at a time of unprecedented disruption.

Therefore, Terrapinn will provide a digital venue that serves as a forum for information exchange and bring together key stakeholders from pharma/biotech, HTAs, Payers and solution providers.

There’s never been a better time for the life science community to connect, collaborate and share ideas.

Until we meet again in person, our commitment is to deliver this by using the most innovative digital tools in the most innovative way. Join us. BOOK TICKETS NOW

Meet our 200+ speakers

Thomas Mueller
Head of Directorate General 1 "Drugs Medical Devices Biotechnology"
Federal Ministry of Health for Germany
Thomas Mueller speaking at Pharma Pricing Market Access & Evidence Congress
Caridad Pontes
Manager of Pharmacotherapeutic Harmonization
Catalan Health Service
Caridad Pontes speaking at Pharma Pricing Market Access & Evidence Congress
Carla Deakin
Programme Director – Commercial & Managed Accesss
NICE
Carla Deakin speaking at Pharma Pricing Market Access & Evidence Congress
Marcus Guardian
Chief Operating Officer
EUnetHTA
Marcus Guardian speaking at Pharma Pricing Market Access & Evidence Congress
Alexander Natz
Secretary General
European Confederation of Pharmaceutical Entrepreneurs
Alexander Natz speaking at Pharma Pricing Market Access & Evidence Congress
Wim Goettsch
Special HTA Advisor
National Health Care Institute (Zorginstituut Nederland)
Wim Goettsch speaking at Pharma Pricing Market Access & Evidence Congress
Navin Joshi
Global Head of Pricing & Access Capabilities
GlaxoSmithKline
Navin Joshi speaking at Pharma Pricing Market Access & Evidence Congress
Bharat Tewarie
Executive Vice President and Chief Marketing Officer
UCB
Bharat Tewarie speaking at Pharma Pricing Market Access & Evidence Congress
Gavin Lewis
Vice President for Value, Access and Policy
Amgen
Gavin Lewis speaking at Pharma Pricing Market Access & Evidence Congress
Wills Hughes-Wilson
Head of Patient Access & Commercial Planning
Mereo Biopharma
Wills Hughes-Wilson speaking at Pharma Pricing Market Access & Evidence Congress
Stefan Holmstrom
Head, HTA Strategy and PRO excellence
Astellas
Stefan Holmstrom speaking at Pharma Pricing Market Access & Evidence Congress
Claudia Neuber
Head of Global Pricing Implementation, Global Market Access and Pricing
AstraZeneca
Claudia Neuber speaking at Pharma Pricing Market Access & Evidence Congress
Tamir Singer
Head of Commercial Development, Specialized Commissioning
NHS England
Tamir Singer speaking at Pharma Pricing Market Access & Evidence Congress
Sheela Upadhyaya
Associate Director Highly Specialised Technologies, Centre for Health Technology Evaluation
NICE
Sheela Upadhyaya speaking at Pharma Pricing Market Access & Evidence Congress
Sofie Alverlind
Project Manager 
Swedish Association of Local Authorities and Regions 
Sofie Alverlind speaking at Pharma Pricing Market Access & Evidence Congress
Elena Lungu
Manager Of Policy Development, Patented Medicine Prices Review Board
Govenment of Canada
Elena Lungu speaking at Pharma Pricing Market Access & Evidence Congress
Oresta Piniazhko
Director, HTA Department, State Expert Centre and Member, Expert Committee
Ministry of Health of Ukraine
Oresta Piniazhko speaking at Pharma Pricing Market Access & Evidence Congress
Nuriya Musina
Head of Development, Center of Healthcare Quality Assessment and Control
Ministry of Health of the Russian Federation
Nuriya Musina speaking at Pharma Pricing Market Access & Evidence Congress
Ulf Staginnus
Senior Vice President, Head Global Market Access & Pricing  
Ipsen
Ulf Staginnus speaking at Pharma Pricing Market Access & Evidence Congress
Diane Munch
VP, Global Pricing, Patient & Health Impact
Pfizer
Diane Munch speaking at Pharma Pricing Market Access & Evidence Congress
Lisette Kaskens
Senior Global Market Access Manager
Advanced Accelerator Applications  
Lisette Kaskens speaking at Pharma Pricing Market Access & Evidence Congress
Sarah Pitluck
Head, Global Pricing And Reimbursement
Spark Therapeutics
Sarah Pitluck speaking at Pharma Pricing Market Access & Evidence Congress
Martin Price
Vice President, Health Economics, Market Access & Reimbursement
Janssen
Martin Price speaking at Pharma Pricing Market Access & Evidence Congress
Sune Lindgaard
Head of Section - Business Intelligence and Health Economy
Amgros
Sune Lindgaard speaking at Pharma Pricing Market Access & Evidence Congress
Shanthy Krishnarajah
Sr. Director, Market Access and Strategy
Seqirus
Shanthy Krishnarajah speaking at Pharma Pricing Market Access & Evidence Congress
Goedele van Haasteren
Staff Member
Ministry of Health of Switzerland
Goedele van Haasteren speaking at Pharma Pricing Market Access & Evidence Congress
Evert Jan van Lente
Director EU-Affairs, AOK-Bundesverband and Chair
Medev
Evert Jan van Lente speaking at Pharma Pricing Market Access & Evidence Congress
Antje Behring 
Acting Head
G-BA
Antje Behring  speaking at Pharma Pricing Market Access & Evidence Congress
Steinar Madsen
Medical Director
Norwegian Medicines Agency
Steinar Madsen speaking at Pharma Pricing Market Access & Evidence Congress
Michael Ermisch
Fachreferent
GKV-Spitzenverband 
Michael Ermisch speaking at Pharma Pricing Market Access & Evidence Congress
Bradley Burnam
CEO
Turn Therapeutics 
Bradley Burnam speaking at Pharma Pricing Market Access & Evidence Congress
Angelina Irizari Policarpio
Head of HEOR and Real World Evidence Communications
Eisai
Angelina Irizari Policarpio speaking at Pharma Pricing Market Access & Evidence Congress
Diann Potestio
VP Market Access
Ascendis Pharma
Diann Potestio speaking at Pharma Pricing Market Access & Evidence Congress
Reg Waldeck
Market Access Strategy Leader
Bayer
Reg Waldeck speaking at Pharma Pricing Market Access & Evidence Congress
Ramon Hernandez Vecino
Head of Real World Evidence Data & Analytics Engagement Lead R&D
Sanofi
Ramon Hernandez Vecino speaking at Pharma Pricing Market Access & Evidence Congress
Kevin Loth
Vice President, Corporate Affairs and Policy, Worldwide Markets 
Celegene 
Kevin Loth speaking at Pharma Pricing Market Access & Evidence Congress

 

VIEW MORE

Who attends

AMS

 

 

DOWNLOAD PROSPECTUS

 

How does it work?

100+ International Speakers

Covering key therapy areas and development stages up to commercialisation and market access we are selecting some of the most important developers and industry leaders from around the world to give virtual talks sharing their insights and knowledge

 

Live panel discussions

We have curated panels of 4-5 industry experts to discuss key issues and answer some of your burning questions. You’ll be able to watch them live, pose questions to the panel and watch later on-demand

 

Virtual roundtables

This is where it gets really interactive. Join a virtual roundtable on a topic of your choice, then virtually meet, discuss and network with developers facing the same issues.

 

Meet (virtually) face to face

Virtual meetings have become the new norm. You can select those you’d like to meet from the list of registered participants. We’ll then set up and host a virtual meeting with you and your selected participants.

 

"Excellent speakers and really good chance to network"

Director Worldwide HEOR, BMS

"Great networking; very useful to hear from a mix of pharma companies and payers about market access and evidence requirements”

Head Global Pricing & Market Access, Vifor Pharma

"This has a very good coverage of the topics & a look in the future. I always get away with more solutions and creativity"

Senior Director Market Access & Pricing Generics Europe, Teva

“Great opportunity to gain payer and industry insights in several 'hot' topics”

Health Care Environment Manager EU Plus, Medac

Stay up to date on the latest Pharma Pricing Market Access & Evidence Congress news

Sign Up for Event Updates

By submitting, you agree to receive email communications from Pharma Pricing Market Access & Evidence Congress, including upcoming promotions and discounted tickets, news, and access to exclusive invite-only events.

Get Involved With Evidence, Pricing and Access Congress

 

To sponsor or exhibit:


Edmond Rama
+44 (0)207 092 1052
edmond.rama@terrapinn.com

To speak:


Chris Shanks
+44 (0)207 092 1151
chris.shanks@terrapinn.com